{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:08:19Z","timestamp":1774314499096,"version":"3.50.1"},"reference-count":12,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypomagnesemia is a well-known complication of long-term proton pump inhibitor usage; the stronger acid-suppressive effect of potassium-competitive acid blockers (P-CABs) may increase the risk of hypomagnesemia to a similar or greater extent. However, reports of P-CAB-associated hypomagnesemia are scarce. A 78-year-old Japanese man with a history of type 2 diabetes and myocardial infarction, who was receiving low-dose aspirin and long-term vonoprazan, presented with epigastric discomfort. Laboratory testing revealed significant hypocalcemia, hypomagnesemia, and low intact parathyroid hormone levels, which were consistent with functional hypoparathyroidism. Electrocardiogram (ECG) showed QTc prolongation and frequent premature ventricular contractions. Urinary magnesium excretion was low, suggesting impaired intestinal magnesium absorption rather than renal loss. Vonoprazan was discontinued, and magnesium and calcium supplementation was initiated. Electrolyte abnormalities normalized by day 3, and ECG changes subsequently resolved. No recurrence occurred after switching to an H2-receptor antagonist. This case demonstrates severe hypomagnesemia and secondary hypocalcemia associated with long-term use of vonoprazan. P-CABs are often used with low-dose aspirin for ulcer prophylaxis against atherosclerotic diseases in patients with diabetes. Clinicians should be aware of hypomagnesemia as an adverse effect of P-CABs and consider periodic monitoring of serum magnesium levels, particularly in high-risk patients, such as those with type 2 diabetes.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag007","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:28:19Z","timestamp":1768307299000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe hypomagnesemia and secondary hypocalcemia associated with vonoprazan in a patient with type 2 diabetes"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4846-9357","authenticated-orcid":false,"given":"Ryoichiro","family":"Aotani","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University , Fukuoka 812-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-7102","authenticated-orcid":false,"given":"Toshiaki","family":"Ohkuma","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University , Fukuoka 812-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University , Fukuoka 812-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichika","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University , Fukuoka 812-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Ago","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University , Fukuoka 812-8582 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"6","key":"2026020822143921800_luag007-B1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","article-title":"AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review","volume":"167","author":"Patel","year":"2024","journal-title":"Gastroenterology"},{"issue":"11","key":"2026020822143921800_luag007-B2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11894-024-00939-3","article-title":"Potassium-competitive acid blockers: current clinical use and future developments","volume":"26","author":"Scarpignato","year":"2024","journal-title":"Curr Gastroenterol Rep"},{"issue":"Supp 1","key":"2026020822143921800_luag007-B3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"Standards of medical care in diabetes-2025","volume":"48","author":"American Diabetes Association","year":"2025","journal-title":"Diabetes Care"},{"issue":"4","key":"2026020822143921800_luag007-B4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00535-021-01769-0","article-title":"Evidence-based clinical practice guidelines for peptic ulcer disease 2020","volume":"56","author":"Kamada","year":"2021","journal-title":"J Gastroenterol"},{"key":"2026020822143921800_luag007-B5","author":"Food and Drug Administration"},{"issue":"4","key":"2026020822143921800_luag007-B6","doi-asserted-by":"crossref","first-page":"e13846","DOI":"10.1111\/apha.13846","article-title":"Mechanisms of proton pump inhibitor-induced hypomagnesemia","volume":"235","author":"Gommers","year":"2022","journal-title":"Acta Physiologica"},{"issue":"1","key":"2026020822143921800_luag007-B7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000542906","article-title":"Severe hypomagnesemia in a patient treated using carboplatin co-administered with vonoprazan","volume":"18","author":"Taniguchi","year":"2025","journal-title":"Case Rep Oncol"},{"issue":"1","key":"2026020822143921800_luag007-B8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2169\/internalmedicine.7325-21","article-title":"Severe hypomagnesemia associated with the long-term use of the potassium-competitive acid blocker vonoprazan","volume":"61","author":"Okamoto","year":"2022","journal-title":"Intern Med"},{"issue":"2","key":"2026020822143921800_luag007-B9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2169\/internalmedicine.7758-21","article-title":"Convulsive seizure due to hypomagnesemia caused by short-term vonoprazan intake","volume":"61","author":"Aiba","year":"2022","journal-title":"Intern Med"},{"issue":"21","key":"2026020822143921800_luag007-B10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMra1510603","article-title":"Magnesium disorders","volume":"390","author":"Touyz","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"2026020822143921800_luag007-B11","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.clnu.2020.12.015","article-title":"The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"40","author":"Leenders","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"2026020822143921800_luag007-B12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3945\/ajcn.112.053132","article-title":"Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies","volume":"98","author":"Del Gobbo","year":"2013","journal-title":"Am J Clin Nutr"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/2\/luag007\/66804699\/luag007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/2\/luag007\/66804699\/luag007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T03:14:46Z","timestamp":1770606886000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag007\/8467205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag007","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,8]]},"article-number":"luag007"}}